Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Fulvestrant|DRUG: Anastrozole
Sponsor: Spanish Breast Cancer Research Group
Collaborators: AstraZeneca